検索キーワード： 薬理学

Depending on which doctor you speak with or which websites you read, cannabis could be an appealing, low-risk medicine—even an aid to wellness—or an insidiously addictive drug rotting the brains of our youth. This dissonance confuses young people, distressed patients, and paralyzes politicians, all while inviting dubious sources of information and resulting in uninformed choices, enhanced polarization, and a fragmented national policy.

This easy-to-use study guide offers comprehensive insight into the critical principles of pharmacology, putting the power of understanding at your fingertips. This top-notch resource dives deep into highly informative topics and provides listeners with the essential details needed to understand complex concepts. From explaining the basics and fundamentals to delving into more intricate detail, this acclaimed handbook covers everything you need to know on your journey to master pharmacology.

Bradwel reminds us that the centenary of this apparent "wonder drug" should be no cause for celebration. Insulin often remains inaccessible to those who need it most: elusive prescriptions, uneven availability and sky-high prices result in rationing and desperate do-it-yourself research and development. In the face of bootstraps rhetoric and "Pharma Bro" capitalists, patients across the world are left to fend for themselves. There is a long way to go in the twenty-first century until insulin truly fulfills the extraordinary promises made by its discovery.

Amanita muscaria mushrooms have a very long history of psychedelic use, but as of recently they've been compared to and/or combined with Delta-9. Now, this is rather ironic, at least to me. I say this, because Amanita muscaria mushrooms actually have an odd interaction with marijunana cannabinoids, besides the legality aspect. To be more specific, the interaction that I'm talking about is between muscimol (the main psychoactive compound in Amanita muscaria mushrooms) and cannabinoids from marijuana plants.

Welcome to "The Methylene Blue Revolution," your indispensable guide to one of the most groundbreaking innovations in modern healthcare. This book aims to educate, enlighten, and empower you with an in-depth understanding of Methylene Blue, a substance that has shown incredible promise in medical research and treatment strategies. If you've been grappling with healthcare woes and felt the pain of stagnation, this is the book that will provide you with actionable solutions.

The audio is focused and high-yield, covering the most important topics you might expect to learn in a typical graduate-level Pharmacology course.

This book is a comprehensive overview of antibiotic pharmacology to help nursing students do well on exams. The audiobook provides essential information for those taking a pharmacology class, as well as those preparing for NCLEX or HESI Exams. It covers topics such as mechanism of action of various antibiotics, drug interactions, side effects, and dosages.

Become a certified pharmacy technician and land the job of your dreams with this comprehensive study guide that will fully prepare you for the PTCB exam! With a passing rate of only 59 percent over the past seven years, the exam has earned a reputation for being extremely difficult.

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.

Whether you are a PharmD, PhD, MD, DPT, DC, or DNP, you likely have a credit card, student loan, and/or mortgage debt you would like to pay down. While your professors worked hard to teach you the ins and outs of clinical practice, it's unlikely they talked about personal finance as often making money is an anathema to being a good clinician and an unwelcome conversation. While debt prevention isn't as sexy as the person who overcame hundreds of thousands of student loan debt, the principles that the authors follow can help you find yourself in a much better financial place.

Can beliefs make you sick? Consider "The June Bug" incident from a US textile factory in the early 1960s. Many employees began to feel dizzy, had an upset stomach, and vomited. Some were even hospitalized. The illness was attributed to a mysterious bug biting workers. However, when the CDC investigated this outbreak, no bugs or any other cause of the illnesses could be identified. Instead, it appears to be an illness caused by the mind -- that is, sickness due to expectation.

There is no doubt that the new incretin weight loss drugs will revolutionize the treatment of obesity, but how exactly. I will explain the current field of obesity treatment. Up to this point I can easily say we are doing a poor job of treating obesity. The incidence of obesity in the United states has been rising over the last 150 years to the point that now we have a 40% incidence of obesity in adults, and it continues to rise.

“Si j’ai écrit ce livre c’est parce que je voulais partager avec vous ce que je connais de l’ARN, ce que je comprends, ce qu’on sait, ce qu’on ne sait pas” Je ne suis pas complotiste mais généticienne, l'une des plus renommées d'après certains. Dans ce livre, je vous dirai ce qu'est l'ARN messager, celui qui compose les vaccins anti-covid. Parce que vous avez le droit de savoir.

Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financializing medicine—from Purdue's rapacious marketing of highly addictive OxyContin through Martin Shkreli's hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.

For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

Llega la versión en audiolibro del best seller escohotadiano Aprendiendo de las drogas, narrado por el propio autor durante dos semanas de grabaciones en Ibiza.